Qingxian X. Cai - Publications

Trajectory-Based Integration of Biomarker Dynamics and Clinical Features for Prognostic Prediction in Hepatocellular Carcinoma: A Retrospective Cohort Study.

Journal: Journal of hepatocellular carcinoma

Published: May 06, 2026

Development and validation of GADA model for diagnosing hepatocellular carcinoma in Chinese hepatitis B patients.

Journal: Chinese medical journal

Published: December 25, 2025

Explainable machine learning incorporating CHI3L1 enhances liver fibrosis staging in chronic hepatitis B: The CHILI multicenter study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 23, 2025

MRI-based clinical-radiologic model to predict the efficacy and prognosis of interventional with systemic therapy in advanced hepatocellular carcinoma: a multicenter study.

Journal: Journal of translational medicine

Published: December 05, 2025

Hemophagocytic lymphohistiocytosis directly triggered by peginterferon alfa-2b in a patient with chronic hepatitis B.

Journal: Frontiers in immunology

Published: December 04, 2025

Non-linear association between metabolic score for insulin resistance and diabetes mellitus in normal-weight middle-aged and older Chinese adults: a multicenter retrospective cohort study.

Journal: Frontiers in nutrition

Published: October 02, 2025

Two-Step Machine Learning Model Enhances Identification of High-Risk Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 10, 2025

The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis.

Journal: Psoriasis (Auckland, N.Z.)

Published: June 21, 2025

Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective.

Journal: Frontiers in pharmacology

Published: February 11, 2025

Severe Rhodococcus equi pneumonia following hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib in hepatocellular carcinoma: a case report.

Journal: BMC infectious diseases

Published: January 27, 2025

Coordination of SLC39A1 and DRP1 facilitates HCC recurrence by impairing mitochondrial quality control.

Journal: Clinical and translational medicine

Published: December 28, 2024

Efficacy and Safety of HSK31679 in Asian Patients With MASLD: A Randomized Controlled Trial.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 30, 2024